Maximilian Rabil, MD
Cards
About
Research
Publications
2026
Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States.
Leapman M, Long J, Westvold S, Rabil M, Sprenkle P, Kim I, Spilberg G, Saperstein L, Fallah J, Suzman D, Lerro C, Xu J, Rivera D, Kluetz P, Karnes R, Dinan M, Mitchell A, Kunst N, Wang S, Ma X, Gross C. Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States. JCO Oncology Practice 2026, op2500617. PMID: 41632928, DOI: 10.1200/op-25-00617.Peer-Reviewed Original ResearchProstate-specific membrane antigen positron emission tomographyPSMA-PETProstate cancerPositron emission tomographyPET imagingNational utilization patternsIncident prostate cancer casesLong-term clinical benefitPSMA PET imagingEmission tomographyProstate cancer casesEvidence of diagnostic accuracyCross-sectional studyClinical benefitCancer casesEligible patientsDiagnostic accuracyProstateInsurance beneficiariesCancerClinical practiceHealth care characteristicsProportion of individualsAdministrative claimsTomographyProstate cancer deaths will decrease by 2050
Brutus N, Rabil M, Kim I. Prostate cancer deaths will decrease by 2050. Urologic Oncology Seminars And Original Investigations 2026, 44: 110971. PMID: 41500928, DOI: 10.1016/j.urolonc.2025.12.007.Peer-Reviewed Original Research
2025
(383) It Comes at Night: Early 1900s Stigma on Nocturnal Emissions and Comparison to Current Views
Rabil M, Cahill E, Honig S. (383) It Comes at Night: Early 1900s Stigma on Nocturnal Emissions and Comparison to Current Views. The Journal Of Sexual Medicine 2025, 22: qdaf320.378. DOI: 10.1093/jsxmed/qdaf320.378.Peer-Reviewed Original ResearchAutomated abstraction algorithm for radical cystectomy surgical outcomes and pathology results.
Palencia P, Rabil M, Jalfon M, Heckscher D, Richmond R, Kong V, Golos A, Chess A, Leapman M, Cavallo J. Automated abstraction algorithm for radical cystectomy surgical outcomes and pathology results. JCO Oncology Practice 2025, 21: 609-609. DOI: 10.1200/op.2025.21.10_suppl.609.Peer-Reviewed Original ResearchInter-rater reliabilityNational Surgical Quality Improvement ProgramEMR-based algorithmsQuality Improvement ProgramPatient safety initiativesNational quality improvement programQuality improvement initiativesImprovement programsInstitutional National Surgical Quality Improvement ProgramQuality metricsSurgical Quality Improvement ProgramSafety initiativesImprovement initiativesCohen's kappa statisticSurgical outcomesSpecification of algorithmsQuality improvementICD-10Kappa statisticText extractionRadical cystectomy outcomesData abstractionReturn to ORAbstraction algorithmAutomated AlgorithmCost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer Evaluation
Kunst N, Long J, Sprenkle P, Kim I, Saperstein L, Rabil M, Ghaffar U, Karnes R, Ma X, Gross C, Wang S, Leapman M. Cost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer Evaluation. JAMA Network Open 2025, 8: e2539250. PMID: 41134573, PMCID: PMC12552925, DOI: 10.1001/jamanetworkopen.2025.39250.Peer-Reviewed Original ResearchConceptsIncremental cost-effectiveness ratioQuality-adjusted life yearsPSMA-PETBiochemical recurrenceProstate cancerProstate-specific membrane antigen positron emission tomographyLow prostate-specific antigen levelsBiochemically recurrent prostate cancerProstate-specific antigen levelMetastatic prostate cancerProstate cancer evaluationStudy of patientsUS academic centersLifetime quality-adjusted life yearsTreatment costsCost-effectiveness ratioPositron emission tomographyDecision-analytic modelDefinitive surgeryRadiation therapyMolecular imagingAntigen levelsBone scanPatient subsetsReflex testHarmonizing environmental and economic forces in urologic care
Rabil M, Choksi A, Leapman M. Harmonizing environmental and economic forces in urologic care. Current Opinion In Urology 2025, 35: 679-684. PMID: 40948360, DOI: 10.1097/mou.0000000000001338.Peer-Reviewed Original ResearchEnvironmental impactAnthropogenic greenhouse gas emissionsSingle-use itemsGreenhouse gas emissionsEcological responsesHuman healthEconomic forcesClimate changeGas emissionsEnvironmental sustainabilityEnvironmental wasteHealthcare systemUrological careBalance approachEconomic valueLower value servicesResource consumptionMature body of researchDelivery of treatmentCare deliverySustainable practicesCare valueSustainabilityLocal marketsUrologic healthAutomated electronic medical record abstraction algorithm for radical prostatectomy outcomes
Rabil M, Jalfon M, Palencia P, Heckscher D, Kong V, Golos A, Richmond R, Chess A, Kim I, Leapman M, Cavallo J. Automated electronic medical record abstraction algorithm for radical prostatectomy outcomes. Urologic Oncology Seminars And Original Investigations 2025, 43: 710.e1-710.e8. PMID: 40885622, DOI: 10.1016/j.urolonc.2025.07.028.Peer-Reviewed Original ResearchInter-rater reliabilityRobot-assisted laparoscopic radical prostatectomyRadical prostatectomyQuality improvementSurgical outcomesRadical prostatectomy outcomesLaparoscopic radical prostatectomyQuality metricsAutomated extractionSurgical marginsUrine leakICD-10Renal insufficiencyOutcome metricsPathological resultsRectal injuryUreteral obstructionText extractionCohen's kappaOutcome matchesAbstraction algorithmCosts of outcomesStatistical significanceProstatectomyAlgorithmKappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant
Mayer F, Stewart A, Varman D, Moritz A, Foster J, Owens A, Areal L, Gowrishankar R, Velez M, Wickham K, Phelps H, Katamish R, Rabil M, Jayanthi L, Vaughan R, Daws L, Blakely R, Ramamoorthy S. Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant. Molecular Psychiatry 2025, 30: 4651-4664. PMID: 40442453, PMCID: PMC12436197, DOI: 10.1038/s41380-025-03055-4.Peer-Reviewed Original ResearchAttention-deficit/hyperactivity disorderKappa-opioid receptor antagonismKappa-opioid receptorsAnomalous DA effluxDA transporterAutism spectrum disorderBipolar disorderDAT Val559D-amphetamineDA releaseAbuse liabilityTreatment of attention-deficit/hyperactivity disorderDopamine transporter variantsModulate DA releaseDA transporter functionSubstance use disordersTargeting kappa opioid receptorsKappa-opioid receptor stimulationHuman DA transporterKOR antagonismDA effluxAberrant dopamineAttention-deficit/hyperactivityDA neuronsSpectrum disorderMP33-07 AUTOMATED ABSTRACTION ALGORITHM FOR RADICAL CYSTECTOMY SURGICAL OUTCOMES
Palencia P, Rabil M, Jalfon M, Heckscher D, Richmond R, Kong V, Golos A, Chess A, Leapman M, Cavallo J. MP33-07 AUTOMATED ABSTRACTION ALGORITHM FOR RADICAL CYSTECTOMY SURGICAL OUTCOMES. Journal Of Urology 2025, 213: e1131. DOI: 10.1097/01.ju.0001110116.40703.0e.07.Peer-Reviewed Original ResearchProstate-Specific Membrane Antigen Imaging Findings and Subsequent Clinical Management Among Patients With Biochemically Recurrent Prostate Cancer
Rabil M, Ghaffar U, Long J, Westvold S, Sprenkle P, Kim I, Saperstein L, Kunst N, Wang S, Ma X, Gross C, Leapman M, Karnes R. Prostate-Specific Membrane Antigen Imaging Findings and Subsequent Clinical Management Among Patients With Biochemically Recurrent Prostate Cancer. JU Open Plus 2025, 3 DOI: 10.1097/ju9.0000000000000278.Peer-Reviewed Original ResearchMetastasis-directed therapyPSMA PET findingsPSMA-PETBiochemical recurrencePSA levelsDistant metastasisProstate cancerLocal therapyProstate-specific membrane antigen positron emission tomographyClinical managementBiochemically recurrent prostate cancerIdentification of distant metastasesNegative PSMA-PETRecurrent prostate cancerRegional nodal diseasePositron emission tomographyNodal diseaseLocal recurrenceInitial therapySystemic therapyTreatment initiationClinical outcomesImaging findingsMetastasisTreatment choice
Academic Achievements & Community Involvement
News
News
- March 09, 2026
Prostate Cancer Deaths to Decrease, Yale Researchers Predict
- October 27, 2025
Yale Urology Research
- July 29, 2025
Yale Urology Research [Q2: April-June 2025]
- June 25, 2025
2025 Yale Urology Visiting Professor and Graduation Day